AndroGel Lawsuits Filed for Stroke and Heart Attack - Attorneys Handling Testosterone Lawsuits Offer No-Cost, No-Obligation AndroGel Case Review
Men taking testosterone replacement drugs face a two- and three-fold risk for heart attack and stroke, recent research has revealed. Federally-approved only for men facing genuine medical problems stemming from low testosterone serum levels known as hypogonadism, testosterone replacement therapies are widely used in the U.S. and around the world for a variety of maladies. Endocrinologists and researchers highlight the lack of evidence supporting the benefits of testosterone therapy, syaing heart attack and stroke risks outweigh the drug’s potential benefits.
In fact, the use of testosterone boosting drugs has tripled in the U.S. since 2001. AbbVie, the maker of AndroGel, and other companies that sell similar testosterone products, have rebranded hypogonadism as “Low T”, launching aggressive disease awareness campaigns that encourage men to self-diagnose. Marketing websites for AndroGel and other testosterone products imply the drug can be used to improve mood, increase libido, and boost energy, while skimming over the cardiovascular risks associated with taking testosterone. Many experts have suggested that marketing for testosterone replacement therapies such as AndroGel has outpaced research on the medical implications of the product. Testosterone products are now the subject of warnings from the FDA and Consumer Reports based on AndroGel heart attack and stroke risks.
Testosterone products have become some of the most popular prescription drugs in the world and have yielded billions in profits to drug companies. Three million prescriptions were written for AndroGel alone during 2012. Total sales of testosterone boosting drugs exceeded $2 billion in 2012, and are projected to reach $5 billion by 2017.
If you or a loved one experienced a stroke or heart attack while taking AndroGel or another similar product, testosterone lawyers believe you may have grounds to file a testosterone lawsuit for damages, harm, or loss suffered as a result of a heart attack or stroke. The makers of AndroGel and other testosterone drugs were aware of the risks of cardiovascular events including heart attack and stroke, yet have continued to market their products widely. Each AndroGel lawsuit that is filed will serve to increase AbbVie’s accountability to consumers for the safety of its product. The AndroGel Testosterone Lawsuit Center serves as a public resource on heart attack risks and stroke risks, including information on testosterone FDA warnings, how to choose an AndroGel lawyer, and how to file a testosterone lawsuit.